U.S. Spine Endoscopy Market (2026 - 2033)

U.S. Spine Endoscopy Market Summary

The U.S. spine endoscopy market size was valued at USD 10.8 million in 2025 and is projected to reach USD 11.7 million in 2026 to USD 20.1 million by 2033, at a CAGR of 8.1% from 2026 to 2033. The market growth is driven by the increasing adoption of minimally invasive spine surgery, the rising prevalence of spinal disorders, and the growing demand for procedures that reduce tissue disruption and recovery time. Technological advancements in endoscopic visualization and instrumentation are further expanding the range of spinal procedures amenable to endoscopic approaches. In addition, the increasing shift toward outpatient and same-day spine procedures is supporting adoption across hospitals and ambulatory surgical centers.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Market Dynamics

The U.S. spine endoscopes market is driven by the increasing adoption of minimally invasive spine surgery, growing preference for outpatient spinal procedures, and advancements in endoscopic visualization and surgical instrumentation. The expansion of ambulatory surgery centers (ASCs) and the growing emphasis on reducing surgical trauma, postoperative pain, and recovery time are supporting the use of endoscopic techniques in selected spinal procedures, including discectomy and decompression. In addition, improvements in endoscope design, visualization capabilities, and specialized surgical instruments are expanding the procedural applications of spine endoscopy across U.S. healthcare facilities.

However, high equipment acquisition costs, the technical complexity of endoscopic procedures, and the need for specialized surgeon training continue to challenge market adoption. The learning curve associated with endoscopic spine surgery and variations in reimbursement and facility-level investment capacity may also limit adoption across certain healthcare settings. Despite these constraints, continued technological innovation, increasing utilization of outpatient spine surgery, expanded surgeon training programs, and growing interest in less invasive treatment approaches are creating opportunities for market expansion.

Market Characteristics

The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The X-axis represents the level of market concentration, ranging from low to high. The Y-axis represents various market characteristics, including industry competition, degree of innovation, level of mergers & acquisition activities, regulatory impact, product substitutes, and regional expansion.

The U.S. market is characterized by a high degree of innovation, as participants compete to differentiate through dedicated spine endoscopes, navigation-enabled platforms, and integrated visualization. For instance, in May 2025, Arthrex received FDA 510(k) clearance for its Spine Endoscope. The reusable endoscope is specifically intended for visualization during spinal endoscopic procedures and minimally invasive surgery.

To learn more about this report, Download Free Sample Report

The U.S. market is characterized by moderate merger and acquisition activity, with the focus of established medical technology companies on adding complementary digital and visualization technologies to their portfolios. For instance, in January 2026, VB Spine agreed to acquire the SpineHawk intraoperative visualization platform from Robotron Surgical Technologies, adding visualization-enabled instruments and AI-enabled image recognition software to its portfolio.

The regulatory environment has a moderate-to-high impact on the U.S. market, since spine endoscopes require FDA 510(k) clearance before commercialization, influencing product development timelines and the pace of new entrants. For instance, in July 2025, Hydrocision received FDA clearance for its SpineSite Endoscope System, about twelve months after its submission was received in July 2024.

The threat from product substitutes is moderate, with endoscopic techniques competing against established open and microscopic or tubular minimally invasive spine procedures. Surgeon familiarity, training requirements, and the learning curve associated with full-endoscopic techniques continue to support these alternatives, particularly for complex cases.

Analyst Perspective

The demand is supported by the shift toward tissue-sparing procedures, shorter recovery pathways, and increasing use of endoscopic visualization during selected spine interventions. Reusable spinal endoscopes maintain a strong position due to their established clinical use and broader integration into hospital systems, while disposable and single-use platforms provide an alternative supported by simplified instrument processing and procedure-specific availability. Ambulatory surgery centers provide an expanding demand channel as selected endoscopic spine procedures move toward outpatient care, while adoption remains concentrated in facilities with experienced spine surgeons, appropriate imaging capabilities, and dedicated endoscopic infrastructure.

Product Type Insights

The reusable spinal endoscopes segment accounted for the largest share of 69.45% in 2025, supported by their established use across endoscopic discectomy, decompression, foraminotomy, and other spinal procedures. Reusable systems provide stable visualization and dedicated working channels, supporting repeated use across procedures and compatibility with established endoscopic platforms. For instance, in April 2025, Arthrex received FDA clearance for its Spine Endoscope, a reusable rigid endoscope designed for visualization during spinal endoscopic procedures. The continued availability of reusable systems across major spine endoscopy portfolios supports their established role in clinical practice.

The disposable / single-use spinal endoscopes segment is expected to register the fastest CAGR during the forecast period, supported by the shift of spine procedures toward outpatient settings and the need for simplified equipment management. Single-use systems provide ready-to-use functionality and reduce requirements associated with cleaning, sterilization, and reprocessing. According to Becker’s ASC in May 2025, as high-acuity procedures, including spine surgeries, increasingly transition to outpatient settings, several new spine-focused ASCs have been opened or planned across the U.S. The publication reported that 88% of spinal decompressions and laminectomies and 67% of cervical spinal fusions were expected to be performed in outpatient settings by 2028. The expansion of ASC-based spine care supports demand for single-use endoscopic systems suited to streamlined outpatient workflows.

Setting Insight

The hospitals segment accounted for the largest share of 73.59% in 2025, supported by comprehensive surgical infrastructure, advanced imaging capabilities, and multidisciplinary spine care. Hospitals represent a key setting for spine endoscopy procedures in the U.S., supported by the establishment of dedicated endoscopic spine programs within major academic medical centers and specialized spine institutions. The availability of dedicated programs is also expanding the clinical application of endoscopy across different spinal regions and procedural approaches. Furthermore, the growing procedural activity at leading institutions demonstrates the increasing utilization of endoscopic spine surgery in hospital-based settings, for instance, as of December 2024, Emory Healthcare surgeons performed over 160 endoscopic spine surgeries, including thoracic disc resections, cervical foraminotomies, and lumbar laminectomies, demonstrating the technique’s versatility across spinal regions and clinical indications.

The ambulatory surgery centers (ASCs) segment is expected to register the fastest CAGR during the forecast period, supported by increasing use of endoscopic spine procedures in outpatient care, shorter recovery requirements, and improvements in perioperative management. For instance, a nationwide study published in November 2025 analyzed 3,097 endoscopic spine surgery procedures performed in U.S. ASCs between 2018 and 2022 and reported an increase in procedure volume, particularly in the Western U.S. The findings demonstrate the expanding use of ASCs for endoscopic spine surgery and support demand for endoscopic systems suited to outpatient surgical workflows.

Region Insights

The Southeast accounted for the largest share of 28.80% in 2025, supported by a broad hospital network, established spine surgery infrastructure, and increasing availability of endoscopic procedures across the region. For instance, in March 2025, Northeast Georgia Medical Center Braselton introduced ultra-minimally invasive endoscopic spine surgery using Arthrex technology for conditions such as herniated discs, spinal stenosis, and arthritis. The introduction of endoscopic spine surgery at the facility reflects the expansion of specialized spine care across the Southeast and supports regional demand for endoscopic systems.

To learn more about this report, Download Free Sample Report

The Southwest is expected to register the fastest CAGR during the forecast period, supported by increasing adoption of endoscopic techniques, expansion of specialized spine services, and growing use of minimally invasive procedures. For instance, in September 2025, Banner - University Medical Center Tucson introduced endoscopic spine surgery, with its first patient undergoing the procedure in June 2025. The procedure supports treatment of herniated discs, spinal stenosis, and pinched nerves, with same-day discharge reported for appropriate patients. This expansion of endoscopic spine capabilities in Arizona supports the development of regional minimally invasive spine care.

Key U.S. Spine Endoscopy  Companies:

• Joimax GmbH

• RIWOspine GmbH

• Arthrex

• Armed Inc.

• Johnson & Johnson

• (DePuy Synthes)

• elliquence

• MAXMORESPINE BY HOOGLAND SPINE PRODUCTS

• Nexon Medical

• Unintech GMBH

• KARL STORZ

Recent Developments

• In July 2026, Johnson & Johnson (DePuy Synthes) acquired Expanding Innovations, Inc., a spine-technology company focused on expandable interbody cage technology. The acquisition strengthens DePuy Synthes’ spine portfolio, particularly its lumbar fusion offering.

• In January 2025, KARL STORZ acquired the medical business of T1V, including its CollaboratOR portfolio for displaying and sharing surgical images and clinical information. The acquisition supports KARL STORZ’s digital surgery capabilities and development of integrated surgical visualization solutions.

• In May 2025, Arthrex partnered with SGMC Health to support the hospital’s first endoscopic spine surgery in Valdosta, Georgia. The collaboration included endoscopic spine technology, training, and implementation support for the minimally invasive procedure.

U.S. Spine Endoscopy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global U.S. Spine Endoscopy Market report based on product type, setting, and region.

• Product Type Outlook 2021 - 2033 (Revenue, USD Million), Unit (in 000’ Units), ASP (USD per Unit)

  • Reusable Spinal Endoscopes

    • Uniportal / Full-endoscopic Working-channel Spinal Endoscopes

      • Lumbar Spinal Endoscopes

        • Transforaminal

        • Interlaminar

      • Cervical Spinal Endoscopes

        • Anterior Cervical

        • Posterior Cervical

      • Thoracic Spinal Endoscopes

        • Transforaminal / Posterolateral

        • Interlaminar / Posterior

    • Biportal Spinal Endoscopes

  • Disposable / Single-use Spinal Endoscopes

• Setting Outlook 2021 - 2033 (Revenue, USD Million), Unit (in 000’ Units), ASP (USD per Unit)

  • Hospitals

    • Inpatient

    • Outpatient

  • Ambulatory Surgery Centers (ASCs)

• Region Outlook 2021 - 2033 (Revenue, USD Million), Unit (in 000’ Units), ASP (USD per Unit)

  • Northeast

  • Southeast

  • Midwest

  • Southwest

  • West

Research Methodology

The U.S. spine endoscopy market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each U.S. spine endoscopy segment quantified using the revenue-capture definitions in the table below.

Estimation Model

To learn more about this report, Download Free Sample Report

Market Scope and Revenue Calculation

The market includes reusable and single-use spinal endoscopes used for visualization in lumbar, cervical, and thoracic procedures, covering uniportal and qualifying biportal (UBE) techniques. Camera towers, monitors, light sources, irrigation pumps, RF generators, drills, instruments, access kits, implants, and repair services are excluded.

Market revenue is calculated using annual new-sale units multiplied by the corresponding realized ASP for reusable scopes, and scopes consumed per procedure multiplied by ASP for single-use products. Estimates are reconciled across company revenues, procedure demand, product segments, care settings, and U.S. regions.

Delivered Customizations

This report has been delivered with the following In-depth customizations